Trial intelligence / Profile preview

Oxytocin for ASUD and Post-Traumatic Anxiety

NCT02742532Phase 2Completed

Start
Apr 2017
Primary completion
Jul 2019
Countries
1
01

Overview

A Phase 2 trial of oxytocin nasal spray in alcohol use disorder (AUD), post-traumatic stress disorder (PTSD). Started Apr 2017; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT02742532.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02742532.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call